title: Prevalence of concomitant medications in older HIV+ patients and comparison with general population.
abstract: The increasing population of human immunodeficiency virus (HIV)-infected elderly patients results in a higher number of comorbidities and greater incidence of polypharmacy in addition to antiretroviral therapy (ART). The aim of this study is to describe the use of concomitant medication in older HIV-infected patients and to compare it with older general population.
  
  
  
  The study included HIV-positive outpatients (>49 years) who received ART in 2011. Co-medication dispensed by pharmacies in that year was collected. Defined daily dose (DDD) for each drug was calculated by patient. A comparison was made between the use of co-medication among men between 50 and 64 years old in general population against the HIV-infected population.
  
  
  
  The study was based on 118 patients (77% men), of which 82% took at least one co-medication and 58% at least five. The commonest co-medications used by HIV-positive patients were antibiotics (44%); analgesics (44%); anti-inflammatories (39%); antacids (38%); and psycholeptics (38%). The medicines used for the greatest number of days per HIV-positive patient were those related to the renin-angiotensin system; anti-diabetics; lipid modifying agents; antithrombotics; and calcium channel blockers. In comparison with the general male population, a higher proportion of HIV-infected patients used antibiotics (42 vs 30%, P = 0.018), antiepileptics (16 vs 5%, P = 0.000), psycholeptics (35 vs 17%, P = 0.000) and COPD medications (14 vs 7%, P = 0.008). The duration of antibiotics and psycholeptic use in HIV-infected patients was longer compared to the general population (P < 0.05).
  
  
  
  Older HIV-positive patients frequently take a higher number of co-medication, which increases the risk of adverse events, interactions with other medication, and may lead to poorer treatment adherence.
authors.forename: Mercedes
authors.initials: M
authors.lastname: Gimeno-Gracia
authors.forename: María José
authors.initials: MJ
authors.lastname: Crusells-Canales
authors.forename: Francisco
authors.initials: F
authors.lastname: Javier Armesto-Gómez
authors.forename: María José
authors.initials: MJ
authors.lastname: Rabanaque-Hernández
mesh_terms: D000367:Age Factors; D000700:Analgesics / Q000008:administration & dosage; D000863:Antacids / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D014150:Antipsychotic Agents / Q000008:administration & dosage; D015897:Comorbidity; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006679:HIV Seropositivity; D006801:Humans; D008297:Male; D008875:Middle Aged; D019338:Polypharmacy
chemical_list: D000700:Analgesics; D000863:Antacids; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D014150:Antipsychotic Agents
keywords: Aging,; Antiretroviral therapy,; Dosing; Drug utilization,; HIV/AIDS,